Bliss GVS Pharma Limited — Important, 15-11-2024: Updates

The ESOP Allotment Committee of Bliss GVS Pharma Limited has approved the allotment of 30,000 equity shares under the Employee Stock Option Plan, 2019. This allotment increases the company’s issued, subscribed, and paid-up share capital from Rs. 10,53,02,023 to Rs. 10,53,32,022. The new shares, with a face value of Re. 1 each, have an exercise price of Rs. 43 per share. However, these shares will be subject to a lock-in period of six months, expiring on May 15, 2025. This move indicates the company's ongoing commitment to incentivizing and rewarding its workforce, which can enhance employee satisfaction and retention. Investors should watch closely for how this impacts overall corporate performance and employee engagement in the future.